ArticleBioinformation2025
Molecular docking analysis of zidovudine triphosphate with conserved residues from NS3 protein.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue fever poses a significant global health concern, yet despite extensive research there is no specific antiviral therapy against the infection. Therefore, it is of interest to study the interaction between the highly conserved N-terminal of NS3 protein of DENV-4 and an FDA approved antiviral, zidovudine triphosphate (ZDV-TP), using molecular docking and molecular dynamics (MD) simulation studies. Docking showed significant binding between NS3 protein and ZDV-TP with -7.7 kcal/mol of binding energy. ZDV-TP interacted with the conserved and active site residues of N-terminal NS3 protease including Gly133, Thr134, Ser135, Gly151 and Asn152. These residues are crucial for viral replication and are highly conserved in all the serotypes of DENV. MD simulation studies showed that the NS3-ZDV-TP complex had no major conformational instability with an approximately linear trajectory up to 200 ns simulation. ZDV-TP was well anchored at its binding position and minimized the compactness as compared to NS3 protein only, indicating high affinity for NS3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.